These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
374 related items for PubMed ID: 21862474
1. Indolone-N-oxide derivatives: in vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established antimalarial drugs. Tahar R, Vivas L, Basco L, Thompson E, Ibrahim H, Boyer J, Nepveu F. J Antimicrob Chemother; 2011 Nov; 66(11):2566-72. PubMed ID: 21862474 [Abstract] [Full Text] [Related]
2. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine]. Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M. Sante; 2008 Nov; 18(1):43-7. PubMed ID: 18684691 [Abstract] [Full Text] [Related]
4. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border. Muhamad P, Thiengsusuk A, Phompradit P, Na-Bangchang K. Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919 [Abstract] [Full Text] [Related]
5. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Skinner TS, Manning LS, Johnston WA, Davis TM. Int J Parasitol; 1996 May; 26(5):519-25. PubMed ID: 8818732 [Abstract] [Full Text] [Related]
12. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment. Menard D, Djalle D, Manirakiza A, Yapou F, Siadoua V, Sana S, Matsika-Claquin MD, Nestor M, Talarmin A. Am J Trop Med Hyg; 2005 Aug; 73(2):239-43. PubMed ID: 16103582 [Abstract] [Full Text] [Related]
13. The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: an in vitro study from a malaria endemic region in Yemen. Al-Shamahy H, Al-Harazy AH, Harmal NS, Al-Kabsi AM. Ann Saudi Med; 2007 Aug; 27(6):432-6. PubMed ID: 18059124 [Abstract] [Full Text] [Related]
16. Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali. Traoré K, Diakité SAS, Bah S, Konaté DS, Dabitao D, Sanogo I, Sangaré M, Dama S, Keita B, Doumbouya M, Guindo MA, Doumbia S, Diakité M. Drugs R D; 2020 Sep; 20(3):249-255. PubMed ID: 32557086 [Abstract] [Full Text] [Related]
17. Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates. Chirawurah JD, Ansah F, Nyarko PB, Duodu S, Aniweh Y, Awandare GA. Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):399-406. PubMed ID: 29128848 [Abstract] [Full Text] [Related]
18. In vitro susceptibility of Plasmodium falciparum isolates from Abidjan, Côte d'Ivoire, to artemisinin, chloroquine, dihydroartemisinin and pyronaridine. Brice BK, William Y, Lacina O, Félix Y, Hugues A, Léonardo B, André M, Joseph D. Tanzan J Health Res; 2010 Jan; 12(1):73-9. PubMed ID: 20737832 [Abstract] [Full Text] [Related]
19. In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum. Basco LK, Le Bras J. Am J Trop Med Hyg; 1992 Oct; 47(4):521-7. PubMed ID: 1443351 [Abstract] [Full Text] [Related]
20. Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003. Suwandittakul N, Chaijaroenkul W, Harnyuttanakorn P, Mungthin M, Na Bangchang K. Korean J Parasitol; 2009 Jun; 47(2):139-44. PubMed ID: 19488420 [Abstract] [Full Text] [Related] Page: [Next] [New Search]